BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27997592)

  • 1. Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy.
    Campbell TM; Castro MA; Ponder BA; Meyer KB
    PLoS One; 2016; 11(12):e0168770. PubMed ID: 27997592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation prediction of antiestrogen resistance in breast cancer based on RNA polymerase II binding data.
    Zhang D; Wang G; Wang Y
    BMC Bioinformatics; 2014; 15 Suppl 2(Suppl 2):S10. PubMed ID: 24564526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of upstream transcription factors (TFs) for expression signature genes in breast cancer.
    Zang H; Li N; Pan Y; Hao J
    Gynecol Endocrinol; 2017 Mar; 33(3):193-198. PubMed ID: 27809618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inferring coregulation of transcription factors and microRNAs in breast cancer.
    Wu JH; Sun YJ; Hsieh PH; Shieh GS
    Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.
    Jayavelu ND; Bar N
    BMC Genomics; 2015 Dec; 16():1077. PubMed ID: 26763900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility.
    Wen W; Chen Z; Bao J; Long Q; Shu XO; Zheng W; Guo X
    Nat Commun; 2021 Sep; 12(1):5318. PubMed ID: 34518541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6.
    Yamaguchi N; Nakayama Y; Yamaguchi N
    J Biol Chem; 2017 May; 292(20):8136-8148. PubMed ID: 28270510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide identification of post-translational modulators of transcription factor activity in human B cells.
    Wang K; Saito M; Bisikirska BC; Alvarez MJ; Lim WK; Rajbhandari P; Shen Q; Nemenman I; Basso K; Margolin AA; Klein U; Dalla-Favera R; Califano A
    Nat Biotechnol; 2009 Sep; 27(9):829-39. PubMed ID: 19741643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Potential Prognostic Biomarkers for Breast Cancer Based on lncRNA-TF-Associated ceRNA Network and Functional Module.
    Li X; Zhu J; Qiu J
    Biomed Res Int; 2020; 2020():5257896. PubMed ID: 32802855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3.
    Takaku M; Grimm SA; De Kumar B; Bennett BD; Wade PA
    Nucleic Acids Res; 2020 May; 48(9):4756-4768. PubMed ID: 32232341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.
    Gu F; Hsu HK; Hsu PY; Wu J; Ma Y; Parvin J; Huang TH; Jin VX
    BMC Syst Biol; 2010 Dec; 4():170. PubMed ID: 21167036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXA1 in breast cancer.
    Nakshatri H; Badve S
    Expert Rev Mol Med; 2009 Mar; 11():e8. PubMed ID: 19261198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REACTIN: regulatory activity inference of transcription factors underlying human diseases with application to breast cancer.
    Zhu M; Liu CC; Cheng C
    BMC Genomics; 2013 Jul; 14():504. PubMed ID: 23885756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimming of mammalian transcriptional networks using network component analysis.
    Tran LM; Hyduke DR; Liao JC
    BMC Bioinformatics; 2010 Oct; 11():511. PubMed ID: 20942926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGMD: A novel approach for functional gene module detection in cancer.
    Jin D; Lee H
    PLoS One; 2017; 12(12):e0188900. PubMed ID: 29244808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inferring regulatory element landscapes and transcription factor networks from cancer methylomes.
    Yao L; Shen H; Laird PW; Farnham PJ; Berman BP
    Genome Biol; 2015 May; 16(1):105. PubMed ID: 25994056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.
    Johmura Y; Maeda I; Suzuki N; Wu W; Goda A; Morita M; Yamaguchi K; Yamamoto M; Nagasawa S; Kojima Y; Tsugawa K; Inoue N; Miyoshi Y; Osako T; Akiyama F; Maruyama R; Inoue JI; Furukawa Y; Ohta T; Nakanishi M
    J Clin Invest; 2018 Dec; 128(12):5603-5619. PubMed ID: 30418174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstruction of transcriptional regulatory networks by stability-based network component analysis.
    Chen X; Xuan J; Wang C; Shajahan AN; Riggins RB; Clarke R
    IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(6):1347-58. PubMed ID: 24407294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription Factors in Breast Cancer-Lessons From Recent Genomic Analyses and Therapeutic Implications.
    Zacksenhaus E; Liu JC; Jiang Z; Yao Y; Xia L; Shrestha M; Ben-David Y
    Adv Protein Chem Struct Biol; 2017; 107():223-273. PubMed ID: 28215225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modulator based regulatory network for ERĪ± signaling pathway.
    Wu HY; Zheng P; Jiang G; Liu Y; Nephew KP; Huang TH; Li L
    BMC Genomics; 2012; 13 Suppl 6(Suppl 6):S6. PubMed ID: 23134758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.